Clinical Trials Logo

Asperger Disorder clinical trials

View clinical trials related to Asperger Disorder.

Filter by:
  • None
  • Page 1

NCT ID: NCT02769949 Recruiting - Clinical trials for Autism Spectrum Disorder

Pediatric Patients With Metabolic or Other Genetic Disorders

Start date: May 3, 2016
Phase:
Study type: Observational

Background: Some patients with unusual genetic conditions are referred to the National Institutes of Health (NIH). They may not be eligible to join current research studies. Testing such patients is a good way to improve the skills of research staff. The findings could lead to new processes and research. Objectives: To recruit a diverse group of pediatric subjects with genetic disorders. To give clinic staff hands-on experience working with these patients. Eligibility: Children any age with a known or suspected genetic disorder. Design: Participants will be screened with medical history and physical exam. They may have lab and other tests. Family members may give DNA samples. Participants will have: Medical history Physical exam Height, weight, and other measurements taken. A clinical evaluation of their disorder. They may have: Blood, urine, and saliva samples taken Imaging tests. These may include x-rays, scans, ultrasound, or skeletal survey. A sleep study A visit with other specialists at NIH A genetic test from a commercial lab Medical photographs taken Other tests Participants may have follow-up visits. They may get medical or surgical treatment.

NCT ID: NCT02680015 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Understanding the Effects of Intervention on the Brain in Autism

Start date: August 2010
Phase: N/A
Study type: Interventional

This study examines how the PEERS (Laugeson & Frankel, 2010; Laugeson, 2016) social-behavioral intervention affects social relationships and brain development and function in autistic preschoolers, adolescents, and young adults.

NCT ID: NCT01983189 Terminated - Autism Clinical Trials

Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism

Start date: November 2008
Phase: Phase 2
Study type: Interventional

This study is a trial of low frequency Repetitive Transcranial magnetic stimulation( rTMS) for subjects with autism spectrum disorders, specially targeting repetitive behaviors.

NCT ID: NCT01553240 Terminated - Clinical trials for Autism Spectrum Disorder

Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies

Start date: June 2007
Phase: N/A
Study type: Interventional

This study uses functional brain imaging and noninvasive brain stimulation techniques to study the brain basis of developmental disorders like Autism Spectrum Disorder and Asperger Disorder. Functional magnetic resonance imaging (fMRI) and recently approved FDA treatment of depression, Transcranial magnetic stimulation (TMS) will be used to study the neurocircuitry of certain symptom clusters in developmental disorders.

NCT ID: NCT00965068 Completed - Autism Clinical Trials

Cholesterol in ASD: Characterization and Treatment

Start date: July 28, 2009
Phase: Phase 1/Phase 2
Study type: Interventional

Background: - Autism spectrum disorders (ASD) are developmental disabilities characterized by impaired social interaction and repetitive and/or stereotypical behaviors. Research studies suggest that some individuals with ASD have very low blood cholesterol levels. This low cholesterol level and other abnormal sterol levels may be important markers for subtypes of ASD. Providing additional cholesterol to the diets of children with ASD may help improve behavior. - These findings will guide the medical community in identifying individuals who should be tested for sterol disorders. This study will also help researchers learn whether adding extra cholesterol to the diet will improve behavioral and other autism spectrum characteristics seen in individuals with ASD and low cholesterol. Objectives: - To determine cholesterol levels in children with autism spectrum disorders. - To compare behavioral and other characteristics among children who have autism spectrum disorders and high, low, or normal cholesterol levels. - To determine whether adding cholesterol to the diet will improve behavioral and other characteristics in individuals with ASD and low cholesterol. Eligibility: - Children between the ages of 4 and 12 who have been diagnosed with an autism spectrum disorder. Design: - Initial screening study will involve a collection of blood samples (for study purposes and cholesterol testing). - Children who have low cholesterol levels will take part in a study in which they will receive either cholesterol supplementation or a placebo, and will have detailed physical and psychological examinations to measure possible improvement in behavioral or other characteristics. - Children who have high or normal cholesterol levels will have further blood samples taken, and will undergo an additional set of examinations for comparison purposes. - Researchers may request blood or DNA samples from other family members (parents or siblings), which will be collected through blood draws and cheek swabs.

NCT ID: NCT00251303 Completed - Clinical trials for Autism Spectrum Disorder

Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders

Start date: August 2005
Phase: Phase 2
Study type: Interventional

This study will examine the effectiveness of riluzole for treating Obsessive-Compulsive Disorder in Youth, Including those with Autism Spectrum Disorders.